Showing results (511-520 of 1,103) with videos related to
Sort By:
Pageof 111
Current Gene Therapy|May 13, 2024
Advancements in CRISPR-Based Therapies for Genetic Modulation in Neurodegenerative DisordersBharat Bhushan, Kuldeep Singh, Shivendra Kumar, et al.Current Gene Therapy|May 27, 2024
Human Virus-Like Proteins: Implications for Gene TherapyAya Al Othman, Anna Polyanskaya, Mikhail DurymanovCurrent Gene Therapy|May 23, 2024
SLC2A3 is a Potential Factor for Head and Neck Squamous Cancer Development through Tumor Microenvironment AlterationWei Jiang, Sheng Xu, Ping LiCurrent Gene Therapy|May 24, 2024
Catechin Protects against Lipopolysaccharide-induced Depressive-like Behaviour in Mice by Regulating Neuronal and Inflammatory GenesYanfang Su, Ping Qiu, Li Cheng, et al.Current Gene Therapy|April 16, 2024
Evolution of Prime Editing Systems: Move Forward to the Treatment of Hereditary DiseasesOlga V Volodina, Anastasia R Fabrichnikova, Arina A Anuchina, et al.Current Gene Therapy|January 16, 2026
Targeted TP53 and KRAS Modulation Via AuNP-Mediated RNA Delivery Suppresses Cancer ProgressionMuhammed Dündar, Dilek Çam Derin, İrem Nur Menevşe, et al.Current Gene Therapy|January 16, 2026
Identification and Experimental Validation of NOP10 as a Biomarker for Diffuse Large B-Cell LymphomaTing Zhang, Li He, Yidong ZhuCurrent Gene Therapy|January 8, 2025
The Role of Immunotherapy in Lung Cancer Treatment: Current Strategies, Future Directions, and Insights into Metastasis and Immune MicroenvironmentChen Lu Li, Xin Yuan Ma, Ping YiCurrent Gene Therapy|March 5, 2024
ZNF695, A Potential Prognostic Biomarker, Correlates with Im mune Infiltrates in Cervical Squamous Cell Carcinoma and Endoce rvical Adenocarcinoma: Bioinformatic Analysis and Experimental VerificationXiaojuan Ding, Ailing Wan, Xin Qi, et al.Current Gene Therapy|November 14, 2023
Prediction of SARS-CoV-2 Infection Phosphorylation Sites and Associations of these Modifications with Lung Cancer DevelopmentWei Li, Gen Li, Yuzhi Sun, et al.Pageof 111